Management of Carbapenemase-Producing Enterobacteriaceae in Intensive Care Unit

Authors

  • J.Y. Mootien Service de réanimation médicale, unité de conseil en antibiothérapie, groupe hospitalier région Mulhouse et Sud-Alsace
  • J.-R. Zahar Département de microbiologie clinique, unité de contrôle et de prévention du risque infectieux, groupe hospitalier Paris-Seine-Saint-Denis, AP–HP

DOI:

https://doi.org/10.3166/rea-2018-0058

Keywords:

Cardiac Arrest, Extracorporeal Life Support, Extracorporeal Cardiopulmonary Resuscitation, Prognosis

Abstract

Infections due to carbapenemase-producing enterobacteriaceae may represent a potential threat due to the scarcity of the available therapeutic resources. OXA-48 and OXA-48-like are most prevalent in France. Older agents have become the last resort choices as treatment options are relatively few and combination therapy with optimal administration should be considered. Therapeutic future options as well as randomized controlled trials are needed. Meanwhile, we need to look at experiences of those managing this health problem and promoting better use of antibiotics stands as a sheer necessity.

Downloads

Published

2018-08-29

How to Cite

Mootien, J., & Zahar, J.-R. (2018). Management of Carbapenemase-Producing Enterobacteriaceae in Intensive Care Unit. Médecine Intensive Réanimation, 27(4), 372–380. https://doi.org/10.3166/rea-2018-0058

Issue

Vol. 27 No. 4 (2018): Juillet 2018 / Médecine interne et transversalité

Section

Update